08 11 / 2024
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products,
01 11 / 2024
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
Reports record third quarter 2024 revenue of $7.6 million , representing growth of 24% compared to the third quarter of 2023 Placed seven Growth Direct ® systems in the third quarter of 2024, marking the highest number of system placements since the third quarter of 2021 Included a multi-system
02 08 / 2024
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
Record second quarter 2024 revenue of $6.6 million , representing growth of 32% compared to the second quarter of 2023 150th Growth Direct ® system placed with an existing top 15 global pharma customer First Growth Direct Rapid Sterility system placed with an existing top 10 global pharma customer
03 05 / 2024
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
Reports first quarter 2024 total revenue of $5.6 million , representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to full year 2023 LOWELL, Mass., May 03, 2024 (GLOBE NEWSWIRE)